DrugCite

Betaseron and Disorientation

This page shows results related to Betaseron and Disorientation from the FDA Adverse Event Reporting System (AERS).

Click here to learn about all Betaseron adverse events.

Adverse Event
Safe Use Tools
Learn More
Comments

Betaseron and Disorientation

Age

50-59 Years
54
40-49 Years
22
>60 Years
17
30-39 Years
6
20-29 Years
2

Gender

Male: 12%
Female: 88%

Outcome

What were the most common outcomes of those reporting Disorientation?

Hospitalization
61
Other
43
Death
3
Disability
3

Reporter

Who most commonly reported Disorientation?

Consumer
35
Physician
17
Other
12

Therapy

Of those reporting Disorientation, why were they taking Betaseron?

Multiple Sclerosis
44
Relapsing-remitting Multiple Sclero...
19
Secondary Progressive Multiple Scle...
9
Progressive Multiple Sclerosis
1

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.*

YESNOUNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?
Probability of an Adverse Event
Doubtful
Possible
Probable
Definite

*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Betaseron, view the complete Betaseron adverse event report.

Scientific Publications on Disorientation

Powered by Google

Comments

Share your experience with Betaseron and Disorientation.